How can the potential of the duocarmycins be unlocked for cancer therapy?
Zoë Jukes, Goreti Ribeiro Morais, Paul M. Loadman, Klaus Pors
Topics & Concepts
ProdrugComputational biologyMedicineDrug discoveryCancer therapyCancerPharmacologyBioinformaticsBiologyInternal medicineCancer therapeutics and mechanismsChemical Synthesis and AnalysisPeptidase Inhibition and Analysis